IP Library Granted Patent US 9,572,882
Granted Patent B2
US 9,572,882 · App. 12/459,112 · Granted Feb 21, 2017

Compositions and methods for improving cardiovascular function

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,572,882
App. No.
12/459,112
Granted
Feb 21, 2017
Kind
B2
Abstract

The present invention relates to methods for supplementing the diet of subjects suffering from cardiovascular disease. D-Ribose is given long term alone or in combination with vasodilators in order to improve or maintain the diastolic or systolic function of the subjects.

Claims (7)

1. A method for improving the cardiovascular function of a subject suffering from coronary artery disease or congestive heart failure, the method consisting of the administration of two to eight grams of D-ribose one to four times daily to the subject for a period longer than three weeks.

2. The method of claim 1 wherein the cardiovascular function is diastolic function.

3. The method of claim 1 wherein the cardiovascular function is systolic function.

4. A method for improving the cardiovascular function of a subject having reduced cardiovascular function, the method consisting of the administration of five to 20 grams of D-ribose daily, divided into doses of one to eight grams for a period longer than three weeks.

5. A method for maintenance of cardiovascular function of a subject having reduced cardiovascular function, the method consisting of the administration of two to eight grams of D-ribose one to four times daily to the subject for a period longer than three weeks.

6. A method for improving the cardiovascular function of a subject suffering from coronary artery disease or congestive heart failure, the method consisting of the administration of two to eight grams of D-ribose plus an effective amount of a vasodilator one to four times daily to the subject for a period longer than three weeks.

7. The method of claim 6 wherein the vasodilator is selected from the group consisting of L-arginine, nitroglycerine, a nitrate, a nitrite, papaverine, isoproterenol, nylidrin, isoxsuprine, nitroprusside, adenosine, xanthine, ethyl alcohol, dipyramide, hydrazaline, minoxidil, and diazoxide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2018
From: BUTLER, TERRI L.; ST. CYR, JOHN; JOHNSON, CLARENCE A.
To: BIOENERGY, INC.
Reel/Frame 046439/0675 →
SECURITY INTEREST Recorded Oct 13, 2015
From: RIBOCOR, INC.
To: HAYDEN JR, H.B. "BUD"
Reel/Frame 036782/0429 →